Amylyx Pharmaceuticals Revenue, Growth & Competitor Profile

DBA AMYLYX

Company Profile & Annual Report for Amylyx Pharmaceuticals

Access the complete profile.

Amylyx Pharmaceuticals Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Address	43 Thorndike St Cambridge, MA 02141

Note: Revenues for privately held companies are statistical evaluations.


Amylyx Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Amylyx Pharmaceuticals's annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • Amylyx Pharmaceuticals is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Amylyx Pharmaceuticals Annual Revenue and Growth Rate

Amylyx Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	Over $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Amylyx Pharmaceuticals's revenues are gauged from an analysis of company filings.

Amylyx Pharmaceuticals's Income Statement (based on Industry Averages)

Amylyx Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Amylyx Pharmaceuticals is developing and marketing. Amylyx Pharmaceuticals's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ROOTED IN CONNECTION Pharmaceutical research and development; pharmaceutical drug development services; testing of pharmaceuticals	08/10/2023
ACT AMYLYX CARE TEAM Downloadable mobile application for patient care management and managing patient medical care information	08/15/2022
ALBRIOZA Pharmaceutical preparations for the treatment of neurological diseases and neurodegenerative diseases	12/17/2021

See all trademarks and details in the Full Report.

Market Share of Amylyx Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Amylyx Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Amylyx Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BIOGEN	Cambridge, MA	100
SAREPTA THERAPEUTICS	Cambridge, MA	36
AMYLYX PHARMACEUTICALS	Cambridge, MA	11
BRAINTREE LABORATORIES	Braintree, MA	8
FOGHORN THERAPEUTICS	Cambridge, MA	5
RECRUITMENT STRATEGIES GROUP	Stoneham, MA	4

Future Competition: Amylyx Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Amylyx Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)